Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PAVmed Inc (PAVM)
NASDAQ:PAVM
PAVmed (PAVM) Stock Price & Analysis
433 Followers
PAVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.60 - $7.75
Previous Close$1.79
Volume58.46K
Average Volume (3M)64.10K
Market Cap
$16.88M
Enterprise Value$67.81M
Total Cash (Recent Filing)$26.41M
Total Debt (Recent Filing)$49.91M
Price to Earnings (P/E)-0.2
Beta1.83
Next Earnings
Aug 13, 2024EPS Estimate
-$1.45Last Dividend Ex-Date
Jan 11, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-9.04
Shares Outstanding9,431,721
10 Day Avg. Volume64,167
30 Day Avg. Volume64,103
Standard Deviation0.25
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.29
Price to Sales (P/S)44.78
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue44.76
Enterprise Value/Gross Profit179.87
Enterprise Value/Ebitda-0.83
Forecast
1Y Price Target
$10.75Price Target Upside500.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
PAVmed News
PremiumCompany Announcements
PAVmed Inc Provides Informal Financial Performance Update
PremiumCompany Announcements
PAVmed Partners with Cancer Center to Advance Care
Bulls Say, Bears Say
Bulls Say
Product CommercializationFocused on commercialization of Lucid and Veris Health, expected to grow significantly, positioning Lucid's high growth and ramp up in commercialization as a major catalyst for PAVmed’s stock.
Regulatory MilestoneThe Veris Cancer Care Platform is poised to advance to the next phase of the FDA approval process.
Strategic PartnershipThe recently signed MOU with OSUCCC is a significant milestone, demonstrating PAVmed's execution of its strategy.
Bears Say
EarningsReported a wider GAAP loss per share, reflecting challenges in profitability.
Financial ForecastAnalysts are lowering revenue estimates for the coming years, suggesting a potential slowdown in growth.
GuidanceManagement did not provide forward guidance, indicating potential uncertainty in future performance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PAVM FAQ
What was PAVmed Inc’s price range in the past 12 months?
PAVmed Inc lowest stock price was $1.60 and its highest was $7.75 in the past 12 months.
What is PAVmed Inc’s market cap?
Currently, no data Available
When is PAVmed Inc’s upcoming earnings report date?
PAVmed Inc’s upcoming earnings report date is Aug 13, 2024 which is in 85 days.
How were PAVmed Inc’s earnings last quarter?
PAVmed Inc released its earnings results on May 14, 2024. The company reported -$2.62 earnings per share for the quarter, missing the consensus estimate of -$1.673 by -$0.947.
Is PAVmed Inc overvalued?
According to Wall Street analysts PAVmed Inc’s price is currently Undervalued.
Does PAVmed Inc pay dividends?
PAVmed Inc pays a Notavailable dividend of $0.55 which represents an annual dividend yield of N/A. See more information on PAVmed Inc dividends here
What is PAVmed Inc’s EPS estimate?
PAVmed Inc’s EPS estimate is -$1.45.
How many shares outstanding does PAVmed Inc have?
PAVmed Inc has 9,431,721 shares outstanding.
What happened to PAVmed Inc’s price movement after its last earnings report?
PAVmed Inc reported an EPS of -$2.62 in its last earnings report, missing expectations of -$1.673. Following the earnings report the stock price went up 15.625%.
Which hedge fund is a major shareholder of PAVmed Inc?
Among the largest hedge funds holding PAVmed Inc’s share is Cruiser Capital Advisors, Llc. It holds PAVmed Inc’s shares valued at N/A.
---
PAVmed Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.75 (500.56% Upside)
$10.75 (500.56% Upside)
Blogger Sentiment
Bullish
PAVM Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 4.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 1.7%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-42.94%
Trailing 12-Months
Company Description
PAVmed Inc
PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The company was founded on June 26, 2014 and is headquartered in New York, NY.
---
PAVM Earnings Call
Q1 2024
0:00 / 0:00
---
PAVM Stock 12 Month Forecast
Average Price Target
$10.75
▲(500.56% Upside)
Technical Analysis
Best Analysts Covering PAVM
1 Year
1 Year Success Rate
5/22 ratings generated profit
1 Year Average Return
-19.82%
reiterated a buy rating 6 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 22.73% of your transactions generating a profit, with an average return of -19.82% per trade.
---